As of Q4'25, Johnson & Johnson's PEG Ratio (5yr expected) stands at -0.25, reflecting a negative value at the latest data point. This suggests that the company's expected earnings growth is not aligned with its current price-to-earnings ratio, potentially indicating undervaluation or negative growth expectations. Over the period from Q1'23 to Q4'25, the PEG Ratio has exhibited significant volatility, with values fluctuating sharply between a high of 14.70 in Q1'23 and a low of -2.94 in Q3'25. The trend shows multiple swings between positive and negative territory, with no sustained period of stability, highlighting considerable uncertainty in growth projections and valuation for JNJ during this timeframe.